BRIDGET SHEPHERD DEPAUL: Open Payments
NPI 1750751517 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,271 in 125 payments from 29 companies in 2025. Trend: 2023 $1,690 · 2024 $2,113 · 2025 $2,271
Food & beverage: $2,271
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $398 |
| Vanda Pharmaceuticals Inc. | 11 | $259 |
| Lilly USA, LLC | 15 | $252 |
| ABBVIE INC. | 21 | $216 |
| PFIZER INC. | 12 | $187 |
| Phathom Pharmaceuticals, Inc. | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Insulet Corporation | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 4 | $58 |
Products named: HETLIOZ, MOUNJARO, Ozempic, Rybelsus, JARDIANCE, NURTEC ODT, UBRELVY, VRAYLAR.
Industry payments across KY — which companies pay providers there.
